ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Charles River Launches Oncology Research Model
contractpharma
April 05, 2017Charles River Laboratories has launched its triple-immunodeficient mouse model, known as the NCG model. The NCG model is the first CRISPR-generated immunodeficient model offered by the company, and was developed by altering the Prkdc and Il2rg genes.
Pharma Sources Insight January 2025
